author-photo

Brian Ramjattan

St. John's University

11

Papers

656

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine

2019 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (7)
Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women

2019 Sexually Transmitted Diseases
Show All
- Source
- Cite
- Save
Citations (2)
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

2016 BMJ Open
Show All
- Source
- Cite
- Save
Citations (21)
Post Hoc Analysis Of The Patricia Randomized Trial Of The Efficacy Of Human Papillomavirus Type 16 (hpv-16)/hpv-18 As04-adjuvanted Vaccine Against Incident And Persistent Infection With Nonvaccine Oncogenic Hpv Types Using An Alternative Multiplex Type-specific Pcr Assay For Hpv Dna

2015 Scopus
Show All
- Source
- Cite
- Save
Citations (0)
Post Hoc Analysis of the PATRICIA Randomized Trial of the Efficacy of Human Papillomavirus Type 16 (HPV-16)/HPV-18 AS04-Adjuvanted Vaccine against Incident and Persistent Infection with Nonvaccine Oncogenic HPV Types Using an Alternative Multiplex Type-Specific PCR Assay for HPV DNA

2015 Clinical and Vaccine Immunology
Show All
- Source
- Cite
- Save
Citations (15)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against incident and persistent infection with non-vaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA: post hoc analysis from the PATRICIA randomized trial

2014 Clinical and Vaccine Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: Results from a randomized study

2014 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (90)
O608 IMMUNE RESPONSE TO THE HPV-16/18 AS04-ADJUVANTED VACCINE ADMINISTERED AS A 2-DOSE OR 3-DOSE SCHEDULE UP TO 3 YEARS AFTER VACCINATION

2012 International Journal of Gynecology & Obstetrics
Show All
- Source
- Cite
- Save
Citations (3)
Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: Results from a randomized study

2011 Human Vaccines
Show All
- Source
- Cite
- Save
Citations (162)
A Randomized, Placebo-Controlled Phase 3 Trial (Study SB-767905/013) of Alvimopan for Opioid-Induced Bowel Dysfunction in Patients With Non-Cancer Pain

2011 The Journal of Pain
Show All
- Source
- Cite
- Save
Citations (57)